相关实验视频
Updated: Jul 8, 2026
07:48
Staining Protocols for Human Pancreatic Islets
Published on: May 23, 2012
贝塔2-糖蛋白I (阿波利波蛋白H) 免疫定位到人类动脉样硬化斑块:对病变进展的潜在影响
J George1, D Harats, B Gilburd
1Research Unit of Autoimmune Diseases, Department of Medicine B; Institute of Lipid and Atherosclerosis Research, Sheba Medical Center, Tel-Hashomer, Israel.
Circulation
|May 5, 1999
概括
β2-糖蛋白I (β2GPI) 存在于人类动脉样硬化斑块中,与内皮细胞和巨细胞有关. 这表明β2GPI可能在影响动脉样硬化进展的免疫中介反应中发挥作用.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- β2-糖蛋白I (β2GPI) 是抗脂抗体的关键标,具有抗凝性质.
- 了解β2GPI在动脉样硬化中的作用对于开发向疗法至关重要.
研究的目的:
- 为了调查β2GPI在人类动脉样硬化斑块中的存在和位置.
- 在体外检查β2GPI与内皮细胞和单细胞巨细胞的关联.
主要方法:
- 对人动脉内关节切除试样进行免疫组化学分析.
- 动脉样硬化病变同质的西部斑分析.
- 使用放射标记β2GPI与人类静脉内皮细胞 (HUVECs) 和U937细胞进行体外研究.
主要成果:
- β2GPI在动脉样硬化斑块的子内皮细胞区域和内密-中介边界表达丰富.
- 在病变中的β2GPI与CD4阳性淋巴细胞结合.
- HUVECs和U937细胞显示了β2GPI的结合,被氧化LDL抑制.
结论:
- 在动脉样硬化病变中存在β2GPI,它与血管细胞和免疫细胞的关联表明它在免疫媒介动脉样硬化中起着作用.
- β2GPI可能是免疫反应的目标,有助于病变的进展.
- 需要进一步研究β2GPI在动脉样硬化中的免疫调节功能.
相关概念视频
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.